A round of Series B financing led by Boston Scientific and Longitude Capital brought in $35.5 million for Maple Grove, Minn.-based Amphora Medical. The proceeds will be used for a US pivotal study to evaluate use of the company's Selective Bladder Denervation System in treating women with overactive bladder.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.